S759 Efficacy and Safety of Mirikizumab in Patients With Ulcerative Colitis: 104-Week Results From a Phase 2 Randomized Controlled Trial. (October 2021) - Panaccione, Remo; Feagan, Brian G.; Redondo, Isabel; Lissoos, Trevor; Selinger, Christian; Arora, Vipin; Lukas, Milan; Matsuoka, Katsuyoshi; Hibi, Toshifumi